Cas:3969-54-8 p-Tolyl Arsonic Acid manufacturer & supplier

We serve Chemical Name:p-Tolyl Arsonic Acid CAS:3969-54-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

p-Tolyl Arsonic Acid

Chemical Name:p-Tolyl Arsonic Acid
CAS.NO:3969-54-8
Synonyms:Tolylarsonic acid;Toluol-arsonsaeure-(4);Arsonic acid,(4-methylphenyl);EINECS 223-588-2;4-Tolylarsonic acid;p-Tolyl-arsonsaeure;p-Toluenearsonic acid;4-methylphenylarsonic acid;p-Methylbenzenearsonic acid;4-methyl-C6H4As(O)(OH)2;p-tolyl-arsonic acid;p-Toluolarsonsaeure;p-methylphenylarsonic acid;p-Tolyl Arsonic Acid
Molecular Formula:C7H9AsO3
Molecular Weight:216.06600
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:431.1ºC at 760mmHg
Density:N/A
Index of Refraction:
PSA:57.53000
Exact Mass:215.97700
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Tolylarsonic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,p-Tolyl Arsonic Acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,p-Methylbenzenearsonic acid Use and application,p-Tolyl Arsonic Acid technical grade,usp/ep/jp grade.


Related News: We also have to consider the degree of concentration and which temperature allows a high quality of API to be manufactured efficiently. p-Tolyl Arsonic Acid manufacturer From the perspective of product structure, the varieties of these enterprises are mainly concentrated in vitamins, antipyretics and analgesics, antibiotics and corticosteroids (ie bulk drug substances). p-Tolyl Arsonic Acid supplier We also have to consider the degree of concentration and which temperature allows a high quality of API to be manufactured efficiently. p-Tolyl Arsonic Acid vendor The Company��s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA. p-Tolyl Arsonic Acid factory We also have to consider the degree of concentration and which temperature allows a high quality of API to be manufactured efficiently.